AUTL vs MELI · rev $71.9M vs P/E 43, rev $19.01B
Autolus Therapeutics Ltd (AUTL) versus MercadoLibre Inc. (MELI) — a side-by-side from cached financials, not a winner call.
Autolus Therapeutics Ltd (AUTL) is a biotechnology company listed on US.
MercadoLibre Inc. (MELI) is a internet retail company listed on NASDAQ.
Latest reported AUTL revenue for 2026-06-30 was $71.9M. Net income was -$110.7M. AUTL currently screens at market cap $614.8M.
Latest reported MELI revenue for 2026-06-30 was $19.01B. Net income was $883.0M. MELI currently screens at market cap $82.73B and trailing P/E 43.1.
AUTL currently screens at market cap $614.8M. MELI currently screens at market cap $82.73B and trailing P/E 43.1.
Not investment advice. Open the AUTL and MELI stock pages for the full models.
Not investment advice.